| MOLOGEN AG: A Further Clinical Study has Currently been Started - a New ... - b3c newswire (press release) |
|
|
b3c newswire (press release) With this MOLOGEN AG product, an innovative cell-based gene therapy for the treatment of advanced renal cancer is entering the first important test phase. |